Department of Radiology

Publications

2016

Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, Ogden RT, et al. A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder. Mol Psychiatry. 2016;21(3):320-7.

Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Pérez JM, Evans AC. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. Nat Commun. 2016;7:11934.

Weidman EK, Foley CP, Kallas O, Dyke JP, Gupta A, Giambrone AE, et al. Evaluating Permeability Surface-Area Product as a Measure of Blood-Brain Barrier Permeability in a Murine Model. AJNR Am J Neuroradiol. 2016;37(7):1267-74.

Ebben MR, Milrad S, Dyke JP, C Phillips D, Krieger AC. Comparison of the upper airway dynamics of oronasal and nasal masks with positive airway pressure treatment using cine magnetic resonance imaging. Sleep Breath. 2016;20(1):79-85.

Zhang Y, Gauthier SA, Gupta A, Comunale J, Chiang GC, Zhou D, et al. Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM). J Magn Reson Imaging. 2016;44(2):426-32.

Reynaud O, Winters KV, Hoang DM, Wadghiri YZ, Novikov DS, Kim SG. Pulsed and oscillating gradient MRI for assessment of cell size and extracellular space (POMACE) in mouse gliomas. NMR Biomed. 2016;29(10):1350-63.

Wen Y, Wang Y, Liu T. Enhancing k-space quantitative susceptibility mapping by enforcing consistency on the cone data (CCD) with structural priors. Magn Reson Med. 2016;75(2):823-30.

Dyke JP, Sondhi D, Voss HU, Yohay K, Hollmann C, Mancenido D, et al. Brain Region-Specific Degeneration with Disease Progression in Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease). AJNR Am J Neuroradiol. 2016;37(6):1160-9.

Chang S, Zhang J, Liu T, Tsiouris AJ, Shou J, Nguyen T, et al. Quantitative Susceptibility Mapping of Intracerebral Hemorrhages at Various Stages. J Magn Reson Imaging. 2016;44(2):420-5.

Pandit-Taskar N, O'Donoghue JA, Ruan S, Lyashchenko SK, Carrasquillo JA, Heller G, et al. First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake. J Nucl Med. 2016;57(12):1858-1864.